LPL Financial
KYNB

LPL Financial’s Kyntra Bio KYNB Stock Holding History

LPL Financial’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-886
Closed -$6.87K – 5603
2025
Q1 		$6.87K Hold
886
– – ﹤0.01% 5328
2024
Q4 		$11.7K Buy
886
+37
+4% +$344 ﹤0.01% 5243
2024
Q3 		$8.47K Sell
849
-560
-40% -$8.45K ﹤0.01% 5137
2024
Q2 		$31.4K Buy
1,409
+960
+214% +$29.7K ﹤0.01% 4894
2024
Q1 		$26.4K Buy
+449
New +$19.3K ﹤0.01% 4823
2021
Q4 		– Sell
-720
Closed -$184K – 4379
2021
Q3 		$184K Sell
720
-23
-3% -$8.15K ﹤0.01% 4012
2021
Q2 		$495K Buy
743
+171
+30% +$98.5K ﹤0.01% 3172
2021
Q1 		$496K Buy
+572
New +$609K ﹤0.01% 3029

Other funds holding KYNB

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

LPL Financial's KYNB Position: Q2 2025 in Review

LPL Financial sold out of Kyntra Bio (KYNB) in Q2 2025, closing a stake of 886 shares — an estimated $6.87K sold.

LPL Financial first reported a position in KYNB in Q1 2021 and held it in 8 quarters. The position peaked at $496K in Q1 2021. 30 funds tracked by Wall St. Rank hold KYNB as of Q2 2025.

  • LPL Financial reported no remaining Kyntra Bio position as of Q2 2025 after selling out during the quarter.
  • LPL Financial sold 886 Kyntra Bio shares in Q2 2025, an estimated $6.87K.
  • LPL Financial first reported a position in Kyntra Bio in Q1 2021 and held it in 8 quarters.
  • LPL Financial's Kyntra Bio position peaked at $496K in Q1 2021.
  • 30 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2025.

Based on LPL Financial's 13F filing for Q2 2025, filed 12 Aug 2025.